LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Nanomedicine-Based Approaches for the Treatment of Dementia
- 1st Edition - October 11, 2022
- Editors: Umesh Gupta, Prashant Kesharwani
- Language: English
- Paperback ISBN:9 7 8 - 0 - 1 2 - 8 2 4 3 3 1 - 2
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 5 9 0 6 - 6
Nanomedicine-Based Approaches for the Treatment of Dementia explores a wide range of promising approaches for the diagnosis and treatment of dementia. The book begins with intr… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteNanomedicine-Based Approaches for the Treatment of Dementia explores a wide range of promising approaches for the diagnosis and treatment of dementia. The book begins with introductory sections on dementia and brain ailments that are followed by further chapters that discuss detailed information about challenges of drug delivery across the blood-brain barrier as well as the current status. This book helps readers design and develop novel drug delivery systems and devices for the treatment of dementia that take advantage of recent advances in nanomedical technologies.
Numerous drug delivery systems have been developed recently for dementia. Unfortunately, most of them are ineffective since dementia is not a single disease. It is an umbrella term for several neurodegenerative conditions which alter brain functions. Due to this, there is an urgent need for innovative technologies/nano drug delivery systems to improve the targeting and delivery of therapeutic as well as diagnostic agents specifically for treating dementia.
- Explores promising approaches for the diagnosis and treatment of dementia
- Discusses advances in cutting-edge nanomedical technologies
- Focuses on the design, synthesis and application of nanocarriers in drug delivery
Basic and clinical researchers in neuroscience, neuropharmacology, and pharmacology
1. Dementia and Neurodegenerative disorders: An Introduction
2. Dementia: Aetiology, Types, Causes and Prevention
3. Receptor attacking ligands for active targeting to Brain
4. Dendrimer based drug delivery for Dementia
5. Polymeric nanoparticles-based drug delivery for Dementia
6. Solid lipid nanoparticles (SLN) based drug delivery for Dementia
7. Liposomes based drug delivery for Dementia
8. Micelles based drug delivery for Dementia
9. Quantum dots-based drug delivery for Dementia
10. Nanocarrier based non-invasive approaches for Dementia
11. Futuristic aspect of nanocarriers on targeted delivery for dementia
2. Dementia: Aetiology, Types, Causes and Prevention
3. Receptor attacking ligands for active targeting to Brain
4. Dendrimer based drug delivery for Dementia
5. Polymeric nanoparticles-based drug delivery for Dementia
6. Solid lipid nanoparticles (SLN) based drug delivery for Dementia
7. Liposomes based drug delivery for Dementia
8. Micelles based drug delivery for Dementia
9. Quantum dots-based drug delivery for Dementia
10. Nanocarrier based non-invasive approaches for Dementia
11. Futuristic aspect of nanocarriers on targeted delivery for dementia
- No. of pages: 318
- Language: English
- Edition: 1
- Published: October 11, 2022
- Imprint: Academic Press
- Paperback ISBN: 9780128243312
- eBook ISBN: 9780323859066
UG
Umesh Gupta
Dr. Umesh Gupta, currently working as Assistant Professor at Department of Pharmacy, Central University of Rajasthan, India, did his bachelor's, master's and doctorate degree in Pharmaceutical Sciences from Dr. H. S. Gour University, India under the mentorship of Prof. NK Jain. He has recently been awarded for “DAAD Research Stays for Academics and Scientists” at Leibniz-institut fur Polymerforschung Dresden, Germany. He has the past experience of Research Scientist at Ranbaxy Research Laboratories, India and Post-Doctoral Research Associate at South Dakota State University, USA. HE is also recipient of Young Scientist Award by Department of Science and Technology, Government of India as well as Ranbaxy Science Scholar Award 2008 by Ranbaxy Research Laboratories, India. He has been awarded more than 3-4 times the overseas travel award by different funding agencies of Indian government to share and present his research at international platform in countries like Germany, USA and Singapore etc. He has more than ten years of research and academic experience. The area of research is mainly focused on dendrimer mediated drug delivery, solubilization and targeting. His laboratory equally focuses on effective brain delivery through nanotechnological carriers such as polymeric micelles, nanoparticles and dendrimers. He has more than 48 publications and seven book chapters to his credit with total citations of more than 2300 (h index of 23 as per Google Scholar).
Affiliations and expertise
Assistant Professor, Department fo Pharmacy, Central University of Rajasthan, IndiaPK
Prashant Kesharwani
Dr. Prashant Kesharwani is an assistant professor of pharmaceutics at School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He has more than 12 years of teaching, research, and industrial experience at international levels from various countries, including the United States, Malaysia, and India. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has more than 300 international publications in well-reputed journals and more than 25 international books (Elsevier). He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award”, most prestigious “Ramanujan Fellowship Award”. He actively participates in outreach and scientific dissemination for the service of the wider community.
Affiliations and expertise
Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, IndiaRead Nanomedicine-Based Approaches for the Treatment of Dementia on ScienceDirect